Effect of Acupressure on Quality of Life, Sleep Quality, and Hopelessness in Older Adults

NCT07435246 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-02-27

No results posted yet for this study

Summary

This randomized controlled study aims to evaluate the effects of acupressure on quality of life, sleep quality, and hopelessness levels in older adults living in a nursing home setting. Aging is associated with decreased sleep quality, reduced life satisfaction, and increased psychological distress, including hopelessness. Non-pharmacological and low-risk interventions are increasingly needed to improve well-being in older populations.

In this study, 50 participants aged 65 years and older were randomly assigned to either an intervention group (acupressure) or a control group (no intervention). The intervention group received acupressure applied to Shenmen (HT7), Neiguan (P6), and Sanyinjiao (SP6) points three times per week for four weeks. The control group received routine care without additional intervention.

Outcomes were measured before and after the intervention using the CASP-19 Quality of Life Scale, the Richard-Campbell Sleep Questionnaire, and the Beck Hopelessness Scale. The study evaluates whether acupressure can serve as a safe and effective complementary nursing intervention to improve sleep and overall well-being in older adults.

Conditions

  • Sleep Disturbance
  • Hopelessness
  • Aging

Interventions

OTHER

Acupressure

Manual acupressure was applied bilaterally to HT7, P6, and SP6 points. Each point was stimulated for approximately two minutes per session. The intervention was administered three times weekly for four consecutive weeks by a trained researcher.

Sponsors & Collaborators

  • Kafkas University

    collaborator OTHER
  • Kocaeli Sağlık ve Teknoloji Üniversitesi

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2025-05-30
Completion
2025-05-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07435246 on ClinicalTrials.gov